Global HIV-AIDS Testing Market 2014-2018

Date: April 25, 2014
Pages: 99
Price:
US$ 2,500.00 US$ 2,000.00
License [?]:
Publisher: Infiniti Research
Report type: Strategic Report
Delivery: E-mail Delivery (PDF), Hard Copy Mail Delivery
ID: G1A246C351AEN
Leaflet:

Download PDF Leaflet

About HIV-AIDS Testing

AIDS is a condition caused due to the gradual weakening of the human body's immune system. This weakening is caused by a virus called HIV, which attacks the body's white blood cells, specifically a subset called CD4 or helper T cells. AIDS/HIV testing devices are medical devices that are used to determine the presence of HIV in human blood. A number of testing devices are available including the HIV antibody test, the Antigen (P24) test, and the PCR test.

TechNavio's analysts forecast the Global HIV-AIDS Testing market will grow at a CAGR of 5.43 percent over the period 2013-2018.

Covered in this Report

The Global HIV-AIDS Testing market can be divided into three segments: HIV-AIDS Screening Assays, HIV-AIDS Confirmatory Assays, and HIV-AIDS Monitoring Assays.

TechNavio's report, the Global HIV-AIDS Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global HIV-AIDS Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions
  • Americas
  • EMEA
  • APAC
Key Vendors
  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Hologic Inc.
  • Ortho-Clinical Diagnostics Inc.
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics Inc.
Other Prominent Vendors
  • bioMerieux SA
  • Calypte Biomedical Corp.
  • Fujirebio Diagnostics Inc.
  • Medical Services International Inc.
  • MedMira Laboratories Inc.
  • OraSure Technologies Inc.
  • Quest Diagnostics Inc.
  • Trinity Biotech plc
Market Driver
  • Increase in Number of People Prone to HIV/AIDS.
  • For a full, detailed list, view our report.
Market Challenge
  • Intense Competition among Vendors.
  • For a full, detailed list, view our report.
Market Trend
  • Adoption of AIDS/HIV Workplace Policies by Companies.
  • For a full, detailed list, view our report.
Key Questions Answered in this Report
  • What will the market size be in 2018 and what will the growth rate be?
  • What are the Key Market Trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
1. EXECUTIVE SUMMARY

2. LIST OF ABBREVIATIONS

3. SCOPE OF THE REPORT

3.1 Market Overview
3.2 Product Offerings

4. MARKET RESEARCH METHODOLOGY

4.1 Market Research Process
4.2 Research Methodology

5. HIV AND AIDS OVERVIEW

  5.1.1 Types of HIV

6. INTRODUCTION

7. MARKET LANDSCAPE

7.1 Market Overview
7.2 Market Size and Forecast
7.3 Five Forces Analysis

8. MARKET SEGMENTATION BY CATEGORY

8.1 Global HIV-AIDS Testing Market by Category

9. TYPES OF HIV TESTS

  9.1.1 Antibody Tests
  9.1.2 Antigen Tests
  9.1.3 PCR Tests

10. GEOGRAPHICAL SEGMENTATION

10.1 Global HIV-AIDS Testing Market by Geographical Segmentation

11. TOP 20 COUNTRIES WITH HIV INFECTED POPULATION

12. BUYING CRITERIA

13. MARKET GROWTH DRIVERS

14. DRIVERS AND THEIR IMPACT

15. MARKET CHALLENGES

16. IMPACT OF DRIVERS AND CHALLENGES

17. MARKET TRENDS

18. TRENDS AND THEIR IMPACT

19. VENDOR LANDSCAPE

19.1 Competitive Scenario
  19.1.1 Key News
  19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2013
19.3 Other Prominent Vendors

20. KEY VENDOR ANALYSIS

20.1 Abbott Laboratories
  20.1.1 Key Facts
  20.1.2 Business Description
  20.1.3 Business Segmentation
  20.1.4 Business Strategy
  20.1.5 Revenue Segmentation
  20.1.6 Revenue Comparison 2012 and 2011
  20.1.7 Geographical Segmentation
  20.1.8 Key Information
  20.1.9 SWOT Analysis
  20.1.10 Strengths
  20.1.11 Weakness
  20.1.12 Opportunities
  20.1.13 Threats
20.2 Bio-Rad Laboratories Inc.
  20.2.1 Key Facts
  20.2.2 Business Description
  20.2.3 Business Segmentation
  20.2.4 Business Strategy
  20.2.5 Revenue Segmentation of Bio-Rad Laboratories Inc.
  20.2.6 Revenue Comparison FY2012 and FY2011
  20.2.7 Bio-Rad Laboratories Inc. by Geographical Segmentation
  20.2.8 Key Information
  20.2.9 SWOT Analysis
  20.2.10 Strengths
  20.2.11 Weakness
  20.2.12 Opportunities
  20.2.13 Threats
20.3 Hologic Inc.
  20.3.1 Key Facts
  20.3.2 Business Description
  20.3.3 Business Segmentation
  20.3.4 Business Strategy
  20.3.5 Revenue Segmentation
  20.3.6 Revenue Comparison FY2012 and FY2013
  20.3.7 Geographical Segmentation
  20.3.8 Key Information
  20.3.9 SWOT Analysis
  20.3.10 Strengths
  20.3.11 Weaknesses
  20.3.12 Opportunities
  20.3.13 Threats
20.4 Ortho-Clinical Diagnostics Inc.
  20.4.1 Key Facts
  20.4.2 Business Overview
  20.4.3 Key Information
  20.4.4 SWOT Analysis
  20.4.5 Strengths
  20.4.6 Weakness
  20.4.7 Opportunities
  20.4.8 Threats
20.5 Roche Diagnostics
  20.5.1 Key Facts
  20.5.2 Business Description
  20.5.3 Business Segmentation
  20.5.4 Revenue Segmentation
  20.5.5 Geographical Segmentation
  20.5.6 Business Strategy
  20.5.7 Key Information
  20.5.8 SWOT Analysis
  20.5.9 Strengths
  20.5.10 Weaknesses
  20.5.11 Opportunities
  20.5.12 Threats
20.6 Siemens Healthcare Diagnostics Inc.
  20.6.1 Key Facts
  20.6.2 Business Overview
  20.6.3 Key Information
  20.6.4 Business Strategy
  20.6.5 SWOT Analysis
  20.6.6 Strengths
  20.6.7 Weaknesses
  20.6.8 Opportunities
  20.6.9 Threats

21. OTHER REPORTS IN THIS SERIES

LIST OF EXHIBITS

Exhibit 1: Market Research Methodology
Exhibit 2: Global HIV-AIDS Testing Market Overview
Exhibit 3: Global HIV-AIDS Testing market 2013-2018 (US$ billion)
Exhibit 4: Global HIV-AIDS Testing Market Segmentation by Category
Exhibit 5: Global HIV-AIDS Testing Market Segmentation by Category 2013
Exhibit 6: Types of HIV Tests
Exhibit 7: Global HIV-AIDS Testing Market by Geographical Segmentation 2013
Exhibit 8: Top 20 HIV Infected Countries with HIV Infected Population 2012
Exhibit 9: Business Segmentation of Abbott Laboratories
Exhibit 10: Revenue Segmentation of Abbott Laboratories 2012
Exhibit 11: Revenue Comparison 2012 and 2011 (US$ million)
Exhibit 12: Abbott Laboratories by Geographical Segmentation 2012
Exhibit 13: Business Segmentation of Bio-Rad Laboratories Inc.
Exhibit 14: Revenue Segmentation of Bio-Rad Laboratories Inc. FY2012
Exhibit 15: Revenue Comparison 2012 and 2011(US$ million)
Exhibit 16: Bio-Rad Laboratories Inc. by Geographical Segmentation 2012
Exhibit 17: Business Segmentation of Hologic Inc.
Exhibit 18: Revenue Segmentation of Hologic Inc. 2013
Exhibit 19: Revenue Comparison FY2012 and FY2013 (US$ million)
Exhibit 20: Hologic Inc. by Geographical Segmentation 2013
Exhibit 21: Business Segmentation of Roche Diagnostics
Exhibit 22: Revenue Segmentation of Roche Diagnostics FY2013
Exhibit 23: Roche Diagnostics by Geographical Segmentation FY2013

COMPANIES MENTIONED

Abbott Laboratories,Bio-Rad Laboratories Inc.,Hologic Inc.,Ortho-Clinical Diagnostics Inc.,Roche Diagnostics,Siemens Healthcare DiagnosticsInc.,bioMerieux SA,Calypte Biomedical Corp.,Fujirebio Diagnostics Inc.,Medical Services International Inc.,MedMira LaboratoriesInc.,OraSure Technologies Inc.,Quest Diagnostics Inc.,Trinity Biotech plc.
Skip to top


Ask Your Question

Global HIV-AIDS Testing Market 2014-2018
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: